---
title: The desk
url: https://craftledge.com/research/workplace-physiotherapy/desk
source: https://craftledge.com/research/workplace-physiotherapy/desk
updated: 2026-08-09
---

# Every sheet this study rests on

The full register behind the workplace physiotherapy read at https://craftledge.com/research/workplace-physiotherapy.

## What the register holds

- 69 sources, each with what was opened and what came from a publisher summary.
- 19 assumptions, each with what would prove it wrong.
- 10 of those assumptions rest on nothing at all.
- 22 gaps searched for and not found.

## The gaps

- **GAP CA 01**. Average cost per accepted claim, by province
- **GAP CA 02**. A single source splitting productivity loss between absence and presenteeism
- **GAP CA 03**. Return on investment for workplace physiotherapy in isolation
- **GAP CA 04**. Claim cost reduction in dollars attributable to early physiotherapy
- **GAP CA 05**. Outcome evaluation of the WorkSafeBC Early Access to Physiotherapy Program: time loss days, claim duration or claim cost
- **GAP CA 06**. Effect of direct access or physiotherapy first pathways on time loss days or recurrence
- **GAP CA 07**. Musculoskeletal claim share broken out by industry sector
- **GAP INT 01**. Sickness absence days per worker per year, and the musculoskeletal share of them
- **GAP INT 02**. A presenteeism measure on a stated methodology
- **GAP INT 03**. A measured indirect to direct cost ratio rather than a modelling convention
- **GAP INT 04**. Cost of work related ill health as a share of national GDP, measured rather than modelled
- **GAP INT 05**. A benefit cost ratio for workplace physiotherapy from the market's own studies
- **GAP INT 06**. Current absence, cost and burden figures for Ireland
- **GAP INT 07**. An EU wide musculoskeletal prevalence and absence measure on one instrument
- **GAP INT 08**. Dutch musculoskeletal burden and absence figures
- **GAP INT 09**. Absence and cost figures for Denmark, Norway and Finland
- **GAP INT 10**. Spanish absence days, cost, and a reference year for the musculoskeletal share
- **GAP INT 11**. Italian absence days and INAIL expenditure attributable to musculoskeletal disease
- **GAP INT 12**. ZUS sickness benefit expenditure attributable to musculoskeletal disease
- **GAP INT 13**. Singaporean absence days and employer cost of work related injury
- **GAP INT 14**. A current Australian musculoskeletal claim share and absence measure
- **GAP SG 01**. A count of Singaporean enterprises at a headcount threshold

Published by craftledge. Start a brief at https://craftledge.com/brief.